Sara Becker
Overview
Explore the profile of Sara Becker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jakubowski A, Patrick B, DiClemente-Bosco K, Salino S, Scott K, Becker S
Res Sq
. 2024 Nov;
PMID: 39502779
Background: Contingency management (CM) is the most effective treatment for stimulant use disorder but is underutilized by opioid treatment programs (OTPs), despite the high prevalence of stimulant use in this...
2.
Biard M, Detcheverry F, Betzner W, Becker S, Grewal K, Azab S, et al.
medRxiv
. 2024 Oct;
PMID: 39371149
Living with dementia requires decision-making about numerous topics including daily activities, such as advance care planning (ACP). Both individuals living with dementia and care partners require informed support for decision-making....
3.
Summersett Williams F, Garofalo R, Karnik N, Donenberg G, Centola H, Becker S, et al.
Addict Sci Clin Pract
. 2024 Sep;
19(1):67.
PMID: 39261950
Background: Adolescents with chronic medical conditions (CMC) use alcohol and marijuana at levels equal to or even greater than their peers without CMC and are more likely to initiate substance...
4.
Mello M, Baird J, Spirito A, Scott K, Zonfrillo M, Lee L, et al.
Subst Use
. 2024 Aug;
18:29768357241272356.
PMID: 39175910
Objective: Screening, brief intervention, and referral to treatment (SBIRT) for adolescent alcohol and drug (AOD) use is recommended to occur with adolescents admitted to pediatric trauma centers. Most metrics on...
5.
Pusnik A, Hartzler B, Vjorn O, Rutkowski B, Chaple M, Becker S, et al.
JMIR Ment Health
. 2024 Aug;
11:e52363.
PMID: 39136186
Background: The COVID-19 social distancing guidelines resulted in a dramatic transition to telephone and video technologies to deliver substance use disorder (SUD) treatment. Before COVID-19, the question was "Will telehealth...
6.
Mello M, Baird J, Spirito A, Lee L, Kiragu A, Scott K, et al.
J Pediatr Surg
. 2024 Aug;
59(11):161618.
PMID: 39097494
Background: Pediatric trauma centers have had challenges meeting the American College of Surgeons criteria for screening and intervening for alcohol with adolescent trauma patients. The study objective was to conduct...
7.
Meier M, Becker S, Levine E, DuFresne O, Foster K, Moore J, et al.
PLoS One
. 2024 Jul;
19(7):e0304135.
PMID: 39074114
Purpose: This study addressed the following questions: 1) Does prior treatment with RAS modulator worsen COVID-19-induced cerebrovascular and cognitive dysfunction? 2) Can post-treatment with RAS modulator improve cognitive performance and...
8.
Ophey A, Wirtz K, Wolfsgruber S, Balzer-Geldsetzer M, Berg D, Hilker-Roggendorf R, et al.
J Neurol
. 2024 Jul;
271(8):5411-5424.
PMID: 38951175
Background: Cognitive reserve (CR) is considered a protective factor for cognitive function and may explain interindividual differences of cognitive performance given similar levels of neurodegeneration, e.g., in Alzheimer´s disease. Recent...
9.
Nardi W, Kelly P, Roy A, Becker S, Brewer J, Sun S
J Subst Use Addict Treat
. 2024 Jun;
165:209442.
PMID: 38889880
Background & Aims: Anxiety and substance use disorders are highly comorbid and represent two of the leading causes of disease burden globally. Psychosocial interventions are important treatment options for people...
10.
Opara I, Pierre K, Cayo S, Aneni K, Mwai C, Hogue A, et al.
JMIR Res Protoc
. 2024 May;
13:e55470.
PMID: 38722676
Background: Substance use continues to remain a public health issue for youths in the United States. Black youths living in urban communities are at a heightened risk of poor outcomes...